http://orcid.org/0000-0003-1822-2237
Citations (83)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Jinfan Sun, Shuenqin Hu & Xiuying Li. (2023) Meta-analysis of the prognostic value of soluble programmed death ligand-1 (sPD-L1) in cancers. Biomarkers 28:6, pages 477-485.
Read now
Read now
Guichan Liao, Ziying Liu, Muye Xia, Hongjie Chen, Houji Wu, Bing Li, Tao Yu, Shaohang Cai, Xiaoyong Zhang & Jie Peng. (2022) Soluble Programmed Cell Death-1 is a Novel Predictor of HBsAg Loss in Chronic Hepatitis B Patients When Long-Term Nucleos(t)ide Analog Treatment is Discontinued. Infection and Drug Resistance 15, pages 2347-2357.
Read now
Read now
Agnieszka Karczmarczyk, Maciej Korpysz, Sylwia Bilska, Joanna Purkot, Marek Hus & Krzysztof Giannopoulos. (2022) Programmed Cell Death-1 and Its Ligands as Targets for Therapy of Multiple Myeloma Patients. Cancer Management and Research 14, pages 1267-1281.
Read now
Read now
Rong Fu, Chuan-Qing Jing, Xiu-Rong Li, Zhao-Feng Tan & Hui-Jie Li. (2021) Prognostic Significance of Serum PD-L1 Level in Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma Treated with Combination Cytotoxic Chemotherapy. Cancer Management and Research 13, pages 4935-4946.
Read now
Read now
Christopher Montemagno, Anais Hagege, Delphine Borchiellini, Brice Thamphya, Olivia Rastoin, Damien Ambrosetti, Juan Iovanna, Nathalie Rioux-Leclercq, Camillio Porta, Sylvie Negrier, Jean-Marc Ferrero, Emmanuel Chamorey, Gilles Pagès & Maeva Dufies. (2020) Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma. OncoImmunology 9:1.
Read now
Read now
Articles from other publishers (78)
Xu Wang, Lingyan Yan, Jihua Guo & Rong Jia. (2024) An anti-PD-1 antisense oligonucleotide promotes the expression of soluble PD-1 by blocking the interaction between SRSF3 and an exonic splicing enhancer of PD-1 exon 3. International Immunopharmacology 126, pages 111280.
Crossref
Crossref
Tatiana N. Zabotina, Antonina I. Chertkova, Anna A. Borunova, Nikolay E. Kushlinskii, Elena S. Gershtein, Elena N. Zakharova, Esma K. Shoua, Vasily T. Tsiklauri, Igor V. Samoylenko, Maxim V. Khoroshilov & Zaira G. Kadagidze. (2023) Membrane (CD8⁺PD-1⁺ and CD4+PD-1⁺) and soluble (sPD-1 and sPD-L1) forms of immune checkpoints in melanoma, breast cancer, and oral mucosal cancer patients: A observational study. Journal of Modern Oncology 25:3, pages 301-307.
Crossref
Crossref
David Digomann, Max Heiduk, Charlotte Reiche, Jessica Glück, Christoph Kahlert, Peter Mirtschink, Anna Klimova, Florian Bösch, Torsten Tonn, Jochen Gaedcke, Michael Ghadimi, Jürgen Weitz, Lena Seifert & Adrian M. Seifert. (2023) Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer. npj Precision Oncology 7:1.
Crossref
Crossref
Yang Ruan, Longlong Xie & Aijun Zou. (2023) Association of CDKN2A/B mutations, PD-1, and PD-L1 with the risk of acute lymphoblastic leukemia in children. Journal of Cancer Research and Clinical Oncology 149:12, pages 10841-10850.
Crossref
Crossref
Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Rocío Granda-Díaz, Alejandra Martínez-Pérez, Candelaria Aguilar-García, Juan P. Rodrigo, Juana M. García-Pedrero & Segundo Gonzalez. (2023) Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy. Molecular Cancer 22:1.
Crossref
Crossref
Anna Hajdara, Uğur Çakır, Barbara Érsek, Pálma Silló, Balázs Széky, Gábor Barna, Shaaban Faqi, Miklós Gyöngy, Sarolta Kárpáti, Krisztián Németh & Balázs Mayer. (2023) Targeting Melanoma-Associated Fibroblasts (MAFs) with Activated γδ (Vδ2) T Cells: An In Vitro Cytotoxicity Model. International Journal of Molecular Sciences 24:16, pages 12893.
Crossref
Crossref
Francesca Romana Mariotti, Tiziano Ingegnere, Nadine Landolina, Paola Vacca, Enrico Munari & Lorenzo Moretta. (2023) Analysis of the mechanisms regulating soluble PD-1 production and function in human NK cells. Frontiers in Immunology 14.
Crossref
Crossref
Daniele Santini, Andrea Botticelli, Antonio Galvano, Michele Iuliani, Lorena Incorvaia, Valerio Gristina, Chiara Taffon, Simone Foderaro, Elisa Paccagnella, Sonia Simonetti, Federico Fazio, Simone Scagnoli, Giulia Pomati, Francesco Pantano, Giuseppe Perrone, Elena De Falco, Antonio Russo & Gian Paolo Spinelli. (2023) Network approach in liquidomics landscape. Journal of Experimental & Clinical Cancer Research 42:1.
Crossref
Crossref
Jian Ruan, Zhihong Zhao, Yuting Qian, Ruilian Xu, Guixiang Liao & Feng-Ming (Spring) Kong. (2023) The predictive role of soluble programmed death ligand 1 in digestive system cancers. Frontiers in Oncology 13.
Crossref
Crossref
Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Alejandra Martínez-Pérez, Ana P. Gonzalez-Rodriguez, Ángel R. Payer, Esther González-García, Candelaria Aguilar-García, Sara González-Rodríguez, Alejandro López-Soto, Alejandra García-Torre & Segundo Gonzalez. (2023) BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia. Cancer Immunology, Immunotherapy 72:7, pages 2529-2539.
Crossref
Crossref
Sai Pan, Wenting Zhao, Yizhan Li, Zhijun Ying, Yihong Luo, Qinchuan Wang, Xiawei Li, Wenjie Lu, Xin Dong, Yulian Wu & Xifeng Wu. (2023) Prediction of risk and overall survival of pancreatic cancer from blood soluble immune checkpoint-related proteins. Frontiers in Immunology 14.
Crossref
Crossref
Rinkee Kumari, Elaheh Sadat Hosseini, Kristen E. Warrington, Tyler Milonas & Kyle K. Payne. (2023) Butyrophilins: Dynamic Regulators of Protective T Cell Immunity in Cancer. International Journal of Molecular Sciences 24:10, pages 8722.
Crossref
Crossref
Daniele Fanale, Chiara Brando, Lidia Rita Corsini, Sofia Cutaia, Mariano Catello Di Donna, Ugo Randazzo, Clarissa Filorizzo, Chiara Lisanti, Luigi Magrin, Vittorio Gurrera, Raffaella Romano, Alessandra Dimino, Tancredi Didier Bazan Russo, Daniel Olive, Salvatore Vieni, Gianni Pantuso, Antonio Giordano, Vito Chiantera, Antonio Russo, Viviana Bazan & Juan Lucio Iovanna. (2023) Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer. BMC Cancer 23:1.
Crossref
Crossref
Se Jun Park, Ju Yeon Park, Kabsoo Shin, Tae Ho Hong, MyungAh Lee, Younghoon Kim & In-Ho Kim. (2023) Clinical significance of serum-derived exosomal PD-L1 expression in patients with advanced pancreatic cancer. BMC Cancer 23:1.
Crossref
Crossref
Clémence Demerlé, Laurent Gorvel, Marielle Mello, Sonia Pastor, Clara Degos, Ana Zarubica, Fabien Angelis, Frédéric Fiore, Jacques A Nunes, Bernard Malissen, Laurent Greillier, Geoffrey Guittard, Hervé Luche, Fabrice Barlesi & Daniel Olive. (2023) Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors. Journal for ImmunoTherapy of Cancer 11:5, pages e006348.
Crossref
Crossref
Ádám Széles, Tamás Fazekas, Szilard Váncsa, Melinda Váradi, Petra Terézia Kovács, Ulrich Krafft, Viktor Grünwald, Boris Hadaschik, Anita Csizmarik, Péter Hegyi, Alex Váradi, Péter Nyirády & Tibor Szarvas. (2022) Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy: a systematic review and meta-analysis. Cancer Immunology, Immunotherapy 72:5, pages 1061-1073.
Crossref
Crossref
Hayden Pearce, Wayne Croft, Samantha M. Nicol, Sandra Margielewska-Davies, Richard Powell, Richard Cornall, Simon J. Davis, Francesca Marcon, Matthew R. Pugh, Éanna Fennell, Sarah Powell-Brett, Brinder S. Mahon, Rachel M. Brown, Gary Middleton, Keith Roberts & Paul Moss. (2023) Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition Is Reversible by Dual Antibody Blockade. Cancer Immunology Research 11:4, pages 435-449.
Crossref
Crossref
Zhifei Gao, Yifeng Bai, Anqi Lin, Aimin Jiang, Chaozheng Zhou, Quan Cheng, Zaoqu Liu, Xin Chen, Jian Zhang & Peng Luo. (2023) Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment. Molecular Cancer 22:1.
Crossref
Crossref
Anna Andrzejczak, Anna Partyka, Andrzej Wiśniewski, Irena Porębska, Konrad Pawełczyk, Kuba Ptaszkowski, Piotr Kuśnierczyk, Monika Jasek & Lidia Karabon. (2023) The association of BTLA gene polymorphisms with non-small lung cancer risk in smokers and never-smokers. Frontiers in Immunology 13.
Crossref
Crossref
Lorena Incorvaia, Gaetana Rinaldi, Giuseppe Badalamenti, Alessandra Cucinella, Chiara Brando, Giorgio Madonia, Alessia Fiorino, Angela Pipitone, Alessandro Perez, Federica Li Pomi, Antonio Galvano, Valerio Gristina, Nadia Barraco, Marco Bono, Tancredi Didier Bazan Russo, Francesca Toia, Adriana Cordova, Daniele Fanale, Antonio Russo & Viviana Bazan. (2023) Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay. Therapeutic Advances in Medical Oncology 15, pages 175883592311518.
Crossref
Crossref
Muttanagouda Giriyappagoudar, Basavaraj Vastrad, Rajeshwari Horakeri & Chanabasayya Vastrad. (2023) Identification and Interaction Analysis of Molecular Markers in Pancreatic Ductal Adenocarcinoma by Bioinformatics and Next-Generation Sequencing Data Analysis. Bioinformatics and Biology Insights 17.
Crossref
Crossref
L. Incorvaia, A. Perez, C. Brando, V. Gristina, M. La Mantia, M. Castiglia, D. Fanale, A. Galvano, G. Badalamenti, A. Russo & V. Bazan. 2023. Liquid Biopsy. Liquid Biopsy
83
117
.
E. Capoluongo, P. Pisapia, U. Malapelle & G. Troncone. 2023. Liquid Biopsy. Liquid Biopsy
119
202
.
Alessandra Dimino, Chiara Brando, Laura Algeri, Valerio Gristina, Erika Pedone, Marta Peri, Alessandro Perez, Ida De Luca, Roberta Sciacchitano, Luigi Magrin, Tancredi Didier Bazan Russo, Marco Bono, Nadia Barraco, Silvia Contino, Maria La Mantia, Antonio Galvano, Giuseppe Badalamenti, Antonio Russo, Viviana Bazan & Lorena Incorvaia. (2022) Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors. Cancers 15:1, pages 216.
Crossref
Crossref
Wenjing Yang, Bo Cheng, Pengxiang Chen, Xiaozheng Sun, Zhihua Wen & Yufeng Cheng. (2022) BTN3A1 promotes tumor progression and radiation resistance in esophageal squamous cell carcinoma by regulating ULK1-mediated autophagy. Cell Death & Disease 13:11.
Crossref
Crossref
Kyung-Soo Chun, Do-Hee Kim, Pawan Kumar Raut & Young-Joon Surh. (2022) Anticancer natural products targeting immune checkpoint protein network. Seminars in Cancer Biology 86, pages 1008-1032.
Crossref
Crossref
Daniele Fanale, Lidia Rita Corsini, Chiara Brando, Sofia Cutaia, Mariano Catello Di Donna, Clarissa Filorizzo, Maria Chiara Lisanti, Ugo Randazzo, Luigi Magrin, Raffaella Romano, Tancredi Didier Bazan Russo, Daniel Olive, Salvatore Vieni, Gianni Pantuso, Vito Chiantera, Antonio Russo, Viviana Bazan & Juan Lucio Iovanna. (2022) Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?. Frontiers in Oncology 12.
Crossref
Crossref
Zexi He, Jun Gu, Ting Luan, Haihao Li, Charles Li, Zhenjie Chen, Enxiu Luo, Jiansong Wang, Yinglong Huang & Mingxia Ding. (2022) Comprehensive analyses of a tumor-infiltrating lymphocytes-related gene signature regarding the prognosis and immunologic features for immunotherapy in bladder cancer on the basis of WGCNA. Frontiers in Immunology 13.
Crossref
Crossref
Anna Kuzevanova, Natalya Apanovich, Danzan Mansorunov, Alexandra Korotaeva & Alexander Karpukhin. (2022) The Features of Checkpoint Receptor—Ligand Interaction in Cancer and the Therapeutic Effectiveness of Their Inhibition. Biomedicines 10:9, pages 2081.
Crossref
Crossref
Cecília A. C. Lima, Luciana M. da Silva, Rogério L. dos Santos, Jerônimo P. A. Silva, Nora M. Forones, Mário R. Martins & Leuridan C. Torres. (2022) Unbalanced expression of sICOS and sPD‐1 correlates with tumor progression in gastric cancer. Journal of Surgical Oncology 126:1, pages 144-149.
Crossref
Crossref
Karolina Wojciechowicz, Marta Spodzieja, Katarzyna A. Lisowska & Anna Wardowska. (2022) The role of the BTLA-HVEM complex in the pathogenesis of autoimmune diseases. Cellular Immunology 376, pages 104532.
Crossref
Crossref
Jonathan Garnier, Olivier Turrini, Anne-Sophie Chretien & Daniel Olive. (2022) Local Ablative Therapy Associated with Immunotherapy in Locally Advanced Pancreatic Cancer: A Solution to Overcome the Double Trouble?—A Comprehensive Review. Journal of Clinical Medicine 11:7, pages 1948.
Crossref
Crossref
Mengke Niu, Yiming Liu, Ming Yi, Dechao Jiao & Kongming Wu. (2022) Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer. Frontiers in Immunology 13.
Crossref
Crossref
Anna Lange, Sara Cajander, Anders Magnuson, Kristoffer Strålin & Olof Hultgren. (2022) Sustained elevation of soluble B- and T- lymphocyte attenuator predicts long-term mortality in patients with bacteremia and sepsis. PLOS ONE 17:3, pages e0265818.
Crossref
Crossref
Ombretta Melaiu, Valeria Lucarini, Roberto Giovannoni, Doriana Fruci & Federica Gemignani. (2022) News on immune checkpoint inhibitors as immunotherapy strategies in adult and pediatric solid tumors. Seminars in Cancer Biology 79, pages 18-43.
Crossref
Crossref
Daniele Fanale, Lidia Rita Corsini, Raimondo Scalia, Chiara Brando, Alessandra Cucinella, Giorgio Madonia, Alessandra Dimino, Clarissa Filorizzo, Nadia Barraco, Marco Bono, Alessia Fiorino, Luigi Magrin, Roberta Sciacchitano, Alessandro Perez, Tancredi Didier Bazan Russo, Gianni Pantuso, Antonio Russo & Viviana Bazan. (2022) Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?. Critical Reviews in Oncology/Hematology 170, pages 103597.
Crossref
Crossref
Xiaoliang Zhao, Dongsheng Yue, Juanjuan Qian, Lei Zhang, Jin Song, Bin Zhang, Chunmei Zhang, Leina Sun, Yuchen Ma, Henghui Zhang & Changli Wang. (2022) Case Report: Sarcoid-Like Reactions and Tertiary Lymphoid Structures Following Dual Checkpoint Inhibition in a Patient with Early-Stage Lung Adenocarcinoma. Frontiers in Immunology 13.
Crossref
Crossref
Zheng Ye, Delin Liu, Dechen Liu, Yinqi Lv, Yidi Zhang, Jun Zhang, Jiantong Bao, Xuelu Yuan, Jiaying Hou & Ling Li. (2022) Immune Infiltration of CD8+ T Cells in Patients With Diabetic Pancreatic Cancer Reduces the Malignancy of Cancer Tissues: An In Silico Study. Frontiers in Endocrinology 12.
Crossref
Crossref
Wataru Murase, Yukino Kamakura, Serina Kawakami, Ayaka Yasuda, Momoka Wagatsuma, Atsuhito Kubota, Hiroyuki Kojima, Tohru Ohta, Mami Takahashi, Michihiro Mutoh, Takuji Tanaka, Hayato Maeda, Kazuo Miyashita & Masaru Terasaki. (2021) Fucoxanthin Prevents Pancreatic Tumorigenesis in C57BL/6J Mice That Received Allogenic and Orthotopic Transplants of Cancer Cells. International Journal of Molecular Sciences 22:24, pages 13620.
Crossref
Crossref
Ryotaro Ohkuma, Katsuaki Ieguchi, Makoto Watanabe, Daisuke Takayanagi, Tsubasa Goshima, Rie Onoue, Kazuyuki Hamada, Yutaro Kubota, Atsushi Horiike, Tomoyuki Ishiguro, Yuya Hirasawa, Hirotsugu Ariizumi, Junji Tsurutani, Kiyoshi Yoshimura, Mayumi Tsuji, Yuji Kiuchi, Shinichi Kobayashi, Takuya Tsunoda & Satoshi Wada. (2021) Increased Plasma Soluble PD-1 Concentration Correlates with Disease Progression in Patients with Cancer Treated with Anti-PD-1 Antibodies. Biomedicines 9:12, pages 1929.
Crossref
Crossref
Maximilian J. Mair, Ayseguel Ilhan-Mutlu, Sahra Pajenda, Barbara Kiesel, Adelheid Wöhrer, Georg Widhalm, Karin Dieckmann, Christine Marosi, Ludwig Wagner, Matthias Preusser & Anna S. Berghoff. (2021) Circulating PD-L1 levels change during bevacizumab-based treatment in recurrent glioma. Cancer Immunology, Immunotherapy 70:12, pages 3643-3650.
Crossref
Crossref
Ruxiang Chen & Ping He. (2021) Long noncoding RNA HOXA-AS2 accelerates cervical cancer by the miR-509-3p/BTN3A1 axis. Journal of Pharmacy and Pharmacology 73:10, pages 1387-1396.
Crossref
Crossref
Muhammad Khan, Sumbal Arooj & Hua Wang. (2021) Soluble B7-CD28 Family Inhibitory Immune Checkpoint Proteins and Anti-Cancer Immunotherapy. Frontiers in Immunology 12.
Crossref
Crossref
Jil M. Jubel, Thomas M. Randau, Janine Becker-Gotot, Sebastian Scheidt, Matthias D. Wimmer, Hendrik Kohlhof, Christof Burger, Dieter C. Wirtz & Frank A. Schildberg. (2021) sCD28, sCD80, sCTLA-4, and sBTLA Are Promising Markers in Diagnostic and Therapeutic Approaches for Aseptic Loosening and Periprosthetic Joint Infection. Frontiers in Immunology 12.
Crossref
Crossref
Fleur van der Sijde, Dana A.M. Mustafa, Eveline E. Vietsch, Peter D. KatsikisCasper H. J. van Eijck. (2021) Circulating Immunological Biomarkers. Pancreas 50:7, pages 933-941.
Crossref
Crossref
Marc Rigau, Adam P. Uldrich & Andreas Behren. (2021) Targeting butyrophilins for cancer immunotherapy. Trends in Immunology 42:8, pages 670-680.
Crossref
Crossref
Zheng Deng, Yi Zheng, Pei Cai & Zheng Zheng. (2021) The Role of B and T Lymphocyte Attenuator in Respiratory System Diseases. Frontiers in Immunology 12.
Crossref
Crossref
Nur Amira Khairil Anwar, Muhammad Najmi Mohd Nazri, Ahmad Hafiz Murtadha, Elis Rosliza Mohd Adzemi, Venugopal Balakrishnan, Khairul Mohd Fadzli Mustaffa, Tengku Ahmad Damitri Al-Astani Tengku Din, Maya Mazuwin Yahya, Juhara Haron & Noor Fatmawati Mokshtar. (2021) Prognostic prospect of soluble programmed cell death ligand-1 in cancer management. Acta Biochimica et Biophysica Sinica 53:8, pages 961-978.
Crossref
Crossref
A. Russo, L. Incorvaia, M. Del Re, U. Malapelle, E. Capoluongo, V. Gristina, M. Castiglia, R. Danesi, M. Fassan, G. Giuffrè, S. Gori, A. Marchetti, N. Normanno, C. Pinto, G. Rossi, D. Santini, A. Sartore-Bianchi, N. Silvestris, P. Tagliaferri, G. Troncone, S. Cinieri & G.D. Beretta. (2021) The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM–SIAPEC-IAP–SIBioC–SIC–SIF Italian Scientific Societies. ESMO Open 6:3, pages 100164.
Crossref
Crossref
Iman M. Ahmad, Alicia J. Dafferner, Kelly A. O’Connell, Kamiya Mehla, Bradley E. Britigan, Michael A. Hollingsworth & Maher Y. Abdalla. (2021) Heme Oxygenase-1 Inhibition Potentiates the Effects of Nab-Paclitaxel-Gemcitabine and Modulates the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma. Cancers 13:9, pages 2264.
Crossref
Crossref
Jong Min Park, Young Min Han, Ho Jae Lee, Sun Jin Hwang, Seong Jin Kim & Ki Baik Hahm. (2021) Transcriptome profiling analysis of the response to walnut polyphenol extract in <i>Helicobacter pylori</i>-infected cells. Journal of Clinical Biochemistry and Nutrition 68:3, pages 201-214.
Crossref
Crossref
Daniele Fanale, Lorena Incorvaia, Giuseppe Badalamenti, Ida De Luca, Laura Algeri, Annalisa Bonasera, Lidia Rita Corsini, Chiara Brando, Antonio Russo, Juan Lucio Iovanna & Viviana Bazan. (2021) Prognostic Role of Plasma PD-1, PD-L1, pan-BTN3As and BTN3A1 in Patients Affected by Metastatic Gastrointestinal Stromal Tumors: Can Immune Checkpoints Act as a Sentinel for Short-Term Survival?. Cancers 13:9, pages 2118.
Crossref
Crossref
Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P Gonzalez-Rodriguez, Ángel R. Payer, Esther González-García, Alejandro López-Soto & Segundo Gonzalez. (2021) BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic Leukemia. Cancers 13:8, pages 1766.
Crossref
Crossref
Bo Chen, Chuan Hu, Liqing Jiang, Zhouxia Xiang, Ziyi Zuo, Yangjun Lin & Chuan Liu. (2021) Exploring the significance of novel immune-related gene signatures in the prognosis and immune features of pancreatic adenocarcinoma. International Immunopharmacology 92, pages 107359.
Crossref
Crossref
Pei Huang, Wei Hu, Ying Zhu, Yushen Wu & Huapeng Lin. (2021) The Prognostic Value of Circulating Soluble Programmed Death Ligand-1 in Cancers: A Meta-Analysis. Frontiers in Oncology 10.
Crossref
Crossref
Gorka Larrinaga, Jon Danel Solano-Iturri, Peio Errarte, Miguel Unda, Ana Loizaga-Iriarte, Amparo Pérez-Fernández, Enrique Echevarría, Aintzane Asumendi, Claudia Manini, Javier C. Angulo & José I. López. (2021) Soluble PD-L1 Is an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma. Cancers 13:4, pages 667.
Crossref
Crossref
Dongsheng Yue, Juanjuan Qian, Zhipeng Chen, Bin Zhang, Peng Chen, Lei Zhang, Jingjing Li, Henghui Zhang & Changli Wang. (2021)
Short-term response to immune-chemotherapy and immune features of a ceritinib-resistant patient with
ROS1
-rearranged lung adenocarcinoma
. Journal for ImmunoTherapy of Cancer 9:2, pages e001967.
Crossref
Crossref
Doo-Won Song, Woong-Bin Ro & Hee-Myung Park. (2021) Evaluation of circulating PD-1 and PD-L1 as diagnostic biomarkers in dogs with tumors. Journal of Veterinary Science 22:5.
Crossref
Crossref
Juan Iovanna. (2021) Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer. Translational Oncology 14:1, pages 100965.
Crossref
Crossref
Olamide T. Olaoba, Funmilayo C. Ligali, Zaccheaus O. Alabi, Amos O. Akinyemi & Kehinde S. Ayinde. (2021) Of immune checkpoint maladies and remedies: The throwing of jabs in the oncogenic ring of PDAC. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1875:1, pages 188483.
Crossref
Crossref
Xiaoyang Li, Yu Zheng & Fei Yue. (2020) Prognostic Value of Soluble Programmed Cell Death Ligand-1 (sPD-L1) in Various Cancers: A Meta-analysis. Targeted Oncology 16:1, pages 13-26.
Crossref
Crossref
Marta Castiglia, Lorena Incorvaia, Valerio Gristina, Umberto Malapelle, Viviana Bazan, Christian Rolfo & Antonio Russo. 2021. Practical Medical Oncology Textbook. Practical Medical Oncology Textbook
99
122
.
Pauline Girard, Eleonora Sosa Cuevas, Benedicte Ponsard, Stephane Mouret, Hugo Gil, Edwige Col, Florence De Fraipont, Nathalie Sturm, Julie Charles, Olivier Manches, Laurence Chaperot & Caroline Aspord. (2021) Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes. Clinical & Translational Immunology 10:11.
Crossref
Crossref
Muhammad Khan, Zhihong Zhao, Sumbal Arooj, Yuxiang Fu & Guixiang Liao. (2020) Soluble PD-1: Predictive, Prognostic, and Therapeutic Value for Cancer Immunotherapy. Frontiers in Immunology 11.
Crossref
Crossref
Lorena Incorvaia, Daniele Fanale, Giuseppe Badalamenti, Chiara Brando, Marco Bono, Ida De Luca, Laura Algeri, Annalisa Bonasera, Lidia Rita Corsini, Salvatore Scurria, Juan Lucio Iovanna, Antonio Russo & Viviana Bazan. (2020) A “Lymphocyte MicroRNA Signature” as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming. Cancers 12:11, pages 3396.
Crossref
Crossref
Linda Quatrini, Francesca Romana Mariotti, Enrico Munari, Nicola Tumino, Paola Vacca & Lorenzo Moretta. (2020) The Immune Checkpoint PD-1 in Natural Killer Cells: Expression, Function and Targeting in Tumour Immunotherapy. Cancers 12:11, pages 3285.
Crossref
Crossref
Ilaria Grazia Zizzari, Chiara Napoletano, Alessandra Di Filippo, Andrea Botticelli, Alain Gelibter, Fabio Calabrò, Ernesto Rossi, Giovanni Schinzari, Federica Urbano, Giulia Pomati, Simone Scagnoli, Aurelia Rughetti, Salvatore Caponnetto, Paolo Marchetti & Marianna Nuti. (2020) Exploratory Pilot Study of Circulating Biomarkers in Metastatic Renal Cell Carcinoma. Cancers 12:9, pages 2620.
Crossref
Crossref
Qian Wang, Jingjing Zhao, Xiaowei Han, Puchun Er, Xiangying Meng, Jinyan Shi, Huiru Sun, Jingyang Zhu, Li Zhu, Shikai Wu, Wencheng Zhang & Bing Sun. (2020) Is There a Role for Post-Mastectomy Radiotherapy for T1-2N1 Breast Cancers With Node-Positive Pathology After Patients Become Node-Negative Pathology Following Neoadjuvant Chemotherapy?. Frontiers in Oncology 10.
Crossref
Crossref
Dhouha Daassi, Kathleen M. Mahoney & Gordon J. Freeman. (2020) The importance of exosomal PDL1 in tumour immune evasion. Nature Reviews Immunology 20:4, pages 209-215.
Crossref
Crossref
Shuzhen Tan, Dongpei Li & Xiao Zhu. (2020) Cancer immunotherapy: Pros, cons and beyond. Biomedicine & Pharmacotherapy 124, pages 109821.
Crossref
Crossref
Ferga C. Gleeson, Michael J. Levy, Rory A. Jackson, Stephen J. Murphy, Kevin C. Halling, Benjamin R. Kipp, Rondell P. Graham & Lizhi Zhang. (2020) Endoscopic ultrasound may be used to deliver gene expression signatures using digital mRNA detection methods to immunophenotype pancreatic ductal adenocarcinoma to facilitate personalized immunotherapy. Pancreatology 20:2, pages 229-238.
Crossref
Crossref
Minh Phuong Dong, Masaru Enomoto, Le Thi Thanh Thuy, Hoang Hai, Vu Ngoc Hieu, Dinh Viet Hoang, Ayako Iida-Ueno, Naoshi Odagiri, Yuga Amano-Teranishi, Atsushi Hagihara, Hideki Fujii, Sawako Uchida-Kobayashi, Akihiro Tamori & Norifumi Kawada. (2020) Clinical significance of circulating soluble immune checkpoint proteins in sorafenib-treated patients with advanced hepatocellular carcinoma. Scientific Reports 10:1.
Crossref
Crossref
Weifeng Tang, Shuchen Chen, Mingqiang Kang, Jun Liu & Chao Liu. (2019)
Investigation of
BTLA
tagging variants with risk of esophagogastric junction adenocarcinoma
. Bioscience Reports 39:12.
Crossref
Crossref
Qinchuan Wang, Jinhua Zhang, Huakang Tu, Dong Liang, David. W. Chang, Yuanqing Ye & Xifeng Wu. (2019) Soluble immune checkpoint-related proteins as predictors of tumor recurrence, survival, and T cell phenotypes in clear cell renal cell carcinoma patients. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Crossref
Zi-juan Qi, Dan Yu, Chun-hong Chen, Hong Jiang, Ran Li & Yong-ming Kang. (2019) The prognostic value of B7H1 and B7H4 expression in pancreatic cancer: A meta-analysis. The International Journal of Biological Markers 34:4, pages 373-380.
Crossref
Crossref
Lorena Incorvaia, Daniele Fanale, Giuseppe Badalamenti, Nadia Barraco, Marco Bono, Lidia Rita Corsini, Antonio Galvano, Valerio Gristina, Angela Listì, Salvatore Vieni, Stefania Gori, Viviana Bazan & Antonio Russo. (2019) Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC). Advances in Therapy 36:10, pages 2600-2617.
Crossref
Crossref
Sireesha Upadhrasta & Lei Zheng. (2019) Strategies in Developing Immunotherapy for Pancreatic Cancer: Recognizing and Correcting Multiple Immune “Defects” in the Tumor Microenvironment. Journal of Clinical Medicine 8:9, pages 1472.
Crossref
Crossref
Etienne Buscail, Charlotte Maulat, Fabrice Muscari, Laurence Chiche, Pierre Cordelier, Sandrine Dabernat, Catherine Alix-Panabières & Louis Buscail. (2019) Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma. Cancers 11:6, pages 852.
Crossref
Crossref